99mTc-Trimethoprim’in Radyosentezi ve Biyodağılımı: Deney Hayvanları Kullanılarak Bakteriyel Enfeksiyon Görüntüleme Için Yeni Bir Radyoişaretli Antibiyotik

Makaleler > Tam Makale · 2018

Yazarlar: Hasan DEMİROĞLU, Gökçen TOPAL, Yasemin PARLAK, Fikriye Gül GÜMÜŞER, Elgin Uluer TÜRKÖZ, Volkan TEKİN, Buket ATEŞ, Perihan ÜNAK, Uğur AVCIBAŞI

Kafkas Universitesi Veteriner Fakultesi Dergisi, Uluslararası, Wos, 2018

DOI: 10.9775/kvfd.2017.19052

Özet

In the present article, we focused on the radiolabeling and evaluation of 99m Tc-TMH complex as a potential candidate for infection imaging in vivo.For this; Trimethoprim (TMH) used to treat bacterial infections was investigated to label with 99m Tc.Labeling was performed using thin (II) chloride as a reducing agent at room temperature for 1 h and radiochemical analysis involved thin layer radiochromatography (TLRC) and high pressure liquid radiochromatograpy (HPLRC) methods.The stability of labeled antibiotic was checked in the presence of rat blood serum at 37 º C up to 180 min.The maximum radiolabeling yield was found to be 96±2% and remained constant at more than 85±1% even in rat serum for 180 min after radiolabeling.Static image of 99m Tc-TMH in male rats demonstrated that important radiation signals are present in the infected site at first glance in 30 min.After 30 min the uptake of the 99m Tc-TMH as ID/g% in the infected muscle (INM) and normal muscle (NM) of the rats were 7.5±1.5% and 5.00±1.2%,respectively.In the INM/NM ratio a desirable behavior was observed as the values for the INM/ NM increased up to 10.6.99m Tc-TMH prepared with high yield is able to localize well in the bacterially infected muscle of the rats.As a result, 99m Tc-TMH may be developed as a radiopharmaceutical agent to distinguish infection from inflammation by nuclear imaging.

Detay görüntüle